Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 11 studies | 23% ± 6% | |
| fibroblast | 11 studies | 23% ± 8% | |
| non-classical monocyte | 6 studies | 22% ± 8% | |
| classical monocyte | 5 studies | 23% ± 4% | |
| conventional dendritic cell | 5 studies | 22% ± 8% | |
| epithelial cell | 5 studies | 39% ± 17% | |
| myeloid cell | 4 studies | 24% ± 7% | |
| plasma cell | 4 studies | 26% ± 11% | |
| monocyte | 4 studies | 19% ± 5% | |
| pancreatic A cell | 3 studies | 37% ± 13% | |
| basal cell | 3 studies | 32% ± 9% | |
| ciliated cell | 3 studies | 25% ± 6% | |
| endothelial cell | 3 studies | 20% ± 6% | |
| abnormal cell | 3 studies | 22% ± 3% | |
| dendritic cell | 3 studies | 34% ± 6% | |
| enterocyte | 3 studies | 19% ± 2% | |
| goblet cell | 3 studies | 16% ± 1% | |
| connective tissue cell | 3 studies | 27% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 100% | 2426.57 | 578 / 578 | 100% | 57.42 | 1155 / 1155 |
| ovary | 100% | 2423.29 | 180 / 180 | 100% | 43.33 | 430 / 430 |
| pancreas | 100% | 1645.31 | 328 / 328 | 100% | 55.66 | 178 / 178 |
| stomach | 100% | 2067.69 | 359 / 359 | 100% | 72.25 | 286 / 286 |
| breast | 100% | 2420.05 | 459 / 459 | 100% | 57.11 | 1117 / 1118 |
| kidney | 100% | 2561.87 | 89 / 89 | 100% | 69.04 | 900 / 901 |
| intestine | 100% | 2163.19 | 966 / 966 | 100% | 75.68 | 526 / 527 |
| bladder | 100% | 2169.00 | 21 / 21 | 100% | 68.70 | 503 / 504 |
| uterus | 100% | 2015.45 | 170 / 170 | 100% | 63.07 | 458 / 459 |
| prostate | 100% | 1540.65 | 244 / 245 | 100% | 57.94 | 502 / 502 |
| liver | 100% | 1808.54 | 225 / 226 | 100% | 63.28 | 404 / 406 |
| esophagus | 100% | 1401.04 | 1444 / 1445 | 98% | 53.89 | 180 / 183 |
| skin | 99% | 2342.07 | 1783 / 1809 | 100% | 66.79 | 470 / 472 |
| adrenal gland | 100% | 3650.16 | 258 / 258 | 98% | 45.90 | 225 / 230 |
| thymus | 100% | 2294.09 | 653 / 653 | 96% | 51.38 | 580 / 605 |
| brain | 97% | 895.94 | 2570 / 2642 | 83% | 28.65 | 585 / 705 |
| adipose | 100% | 2524.02 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2170.42 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 42.60 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 35.27 | 1 / 1 |
| blood vessel | 100% | 1730.09 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 54.86 | 79 / 80 |
| heart | 98% | 1656.26 | 848 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 33.09 | 28 / 29 |
| peripheral blood | 88% | 916.55 | 820 / 929 | 0% | 0 | 0 / 0 |
| muscle | 49% | 239.45 | 395 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016139 | Biological process | glycoside catabolic process |
| GO_2000535 | Biological process | regulation of entry of bacterium into host cell |
| GO_0006004 | Biological process | fucose metabolic process |
| GO_0009617 | Biological process | response to bacterium |
| GO_0035578 | Cellular component | azurophil granule lumen |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005764 | Cellular component | lysosome |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_0004560 | Molecular function | alpha-L-fucosidase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FUCA2 |
| Protein name | Plasma alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase 2) (Alpha-L-fucosidase 2) alpha-L-fucosidase (EC 3.2.1.51) |
| Synonyms | PSEC0151 UNQ227/PRO260 |
| Description | FUNCTION: Alpha-L-fucosidase is responsible for hydrolyzing the alpha-1,6-linked fucose joined to the reducing-end N-acetylglucosamine of the carbohydrate moieties of glycoproteins. |
| Accessions | ENST00000451668.1 Q9BTY2 Q7Z6V2 ENST00000002165.11 [Q9BTY2-1] |